Alkermes plcALKS
Price$40.52Intrinsic value$23.1143% below price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $23.11median of 4 methods · middle span $17-$29based on filings through 30 Jun 2026
Market Price $40.52Price as of 30 Sep 2026
Margin of Safety -43.0%as of 30 Sep 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 5.0% (near-term consensus, capped) · years 2–5: -9.4%/yr (balance of the path).-6.7% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 6-7.0%Yr 7-4.5%Yr 8-2.0%Yr 90.5%Yr 103.0%
-9.4% → 3.0%
Years 11–20: glide to long-run rate
Per-year rates
Yr 113.0%Yr 123.0%Yr 133.0%Yr 143.0%Yr 153.0%Yr 163.0%Yr 173.0%Yr 183.0%Yr 193.0%Yr 203.0%
3.0% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Discount rate (cost of equity) 7.2%
Volatility vs market (adjusted beta)0.51

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetAlkermes plcALKSHealth Care
Valuation
P/E106.6×
P/S4.7×
P/B4.3×
EV / Revenue5.3×
EV / EBITDA34.3×
Profitability
Gross margin—
Operating margin7.0%
Net margin4.0%
FCF margin13.3%
Returns
ROE3.7%
ROA1.5%
ROIC2.4%
Growth
Revenue growth (YoY)7.1%
5-yr fwd EPS growth-6.7%
Financial strength
Debt / Equity0.83×
Current ratio2.30×
Altman Z-Score2.1
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.